Enter the game-changing implant technology that’s transforming sleep apnea treatment. Two notable options have emerged: Genio Nyxoah and Inspire. These devices offer a novel approach to managing ...
The global sleep apnea implants market is expected to grow from USD 317.1 million in 2023 to USD 1,158.1 million by 2033, at ...
For patients with obstructive sleep apnea (OSA), sleep surgery is associated with a significantly reduced risk for mo ...
Many major maladies have been linked to disturbed slumber caused by sleep apnea, high blood pressure, heart problems a ...
It comes as UCLH became the first centre in the UK to offer sleep apnoea patients a choice of nerve stimulators – the Genio Nyxoah or the Inspire implant. Both devices stimulate the hypoglossal ...